Back to calendar
ACADIA Pharmaceuticals Inc. (ACAD) Earnings
ACAD reports earnings on Wednesday, November 4, 2026
earnings report
November 4, 2026 · After Market Close
Q3 2026
Est. EPS: $0.20
Actual EPS: $0.18
EPS surprise: 164.12%
Company overview
Market Cap$3.5B
PriceUSD 20.59
P/E9.27
EPS (TTM)2.22
52-week high30.96
52-week low18.39
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees798